Ignite Creation Date:
2024-05-06 @ 8:04 PM
Last Modification Date:
2024-10-26 @ 3:20 PM
Study NCT ID:
NCT06247319
Status:
RECRUITING
Last Update Posted:
2024-06-17
First Post:
2024-01-29
Brief Title:
Study to Evaluate the Effectiveness of Risankizumab in Participants With a Recent Diagnosis of Moderate Plaque Psoriasis in a Real-life Setting in Greece
Sponsor:
Organization:
AbbVie